These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 8460920

  • 1. Pharmacokinetics and pharmacodynamics of granulocyte-macrophage colony-stimulating factor and zidovudine in patients with AIDS and severe AIDS-related complex.
    Hewitt RG, Morse GD, Lawrence WD, Maliszewski ML, Santora J, Bartos L, Bonnem E, Poiesz B.
    Antimicrob Agents Chemother; 1993 Mar; 37(3):512-22. PubMed ID: 8460920
    [Abstract] [Full Text] [Related]

  • 2. Recombinant human granulocyte-macrophage colony-stimulating factor ameliorates zidovudine-induced neutropenia in patients with acquired immunodeficiency syndrome (AIDS)/AIDS-related complex.
    Levine JD, Allan JD, Tessitore JH, Falcone N, Galasso F, Israel RJ, Groopman JE.
    Blood; 1991 Dec 15; 78(12):3148-54. PubMed ID: 1742482
    [Abstract] [Full Text] [Related]

  • 3. Oral and intravenous zidovudine pharmacokinetics: the effect of granulocyte-macrophage colony stimulating factor.
    Aweeka FT, Mak M, al-Uzri A, Peter K, Dett C, Franco J, Affrime M, Guerciolini R, Cutler DL, Kahn J.
    J Clin Pharmacol; 1995 Sep 15; 35(9):856-64. PubMed ID: 8786245
    [Abstract] [Full Text] [Related]

  • 4. Interferon-alpha, zidovudine, and granulocyte-macrophage colony-stimulating factor: a phase I AIDS Clinical Trials Group study in patients with Kaposi's sarcoma associated with AIDS.
    Krown SE, Paredes J, Bundow D, Polsky B, Gold JW, Flomenberg N.
    J Clin Oncol; 1992 Aug 15; 10(8):1344-51. PubMed ID: 1634925
    [Abstract] [Full Text] [Related]

  • 5. Effects of recombinant human granulocyte colony-stimulating factor on leucopenia in zidovudine-treated patients with AIDS and AIDS related complex, a phase I/II study.
    van der Wouw PA, van Leeuwen R, van Oers RH, Lange JM, Danner SA.
    Br J Haematol; 1991 Jul 15; 78(3):319-24. PubMed ID: 1714756
    [Abstract] [Full Text] [Related]

  • 6. Combined therapy with recombinant granulocyte colony-stimulating factor and erythropoietin decreases hematologic toxicity from zidovudine.
    Miles SA, Mitsuyasu RT, Moreno J, Baldwin G, Alton NK, Souza L, Glaspy JA.
    Blood; 1991 May 15; 77(10):2109-17. PubMed ID: 1709368
    [Abstract] [Full Text] [Related]

  • 7. A phase I/II trial of zidovudine, interferon-alpha, and granulocyte-macrophage colony-stimulating factor in the treatment of human immunodeficiency virus type 1 infection.
    Davey RT, Davey VJ, Metcalf JA, Zurlo JJ, Kovacs JA, Falloon J, Polis MA, Zunich KM, Masur H, Lane HC.
    J Infect Dis; 1991 Jul 15; 164(1):43-52. PubMed ID: 1676045
    [Abstract] [Full Text] [Related]

  • 8. Granulocyte-macrophage colony-stimulating factor mitigates the neutropenia of combined interferon alfa and zidovudine treatment of acquired immune deficiency syndrome-associated Kaposi's sarcoma.
    Scadden DT, Bering HA, Levine JD, Bresnahan J, Evans L, Epstein C, Groopman JE.
    J Clin Oncol; 1991 May 15; 9(5):802-8. PubMed ID: 2016623
    [Abstract] [Full Text] [Related]

  • 9. Influence of varying doses of granulocyte-macrophage colony-stimulating factor on pharmacokinetics and antibody-dependent cellular cytotoxicity.
    Liljefors M, Nilsson B, Mellstedt H, Frödin JE.
    Cancer Immunol Immunother; 2008 Mar 15; 57(3):379-88. PubMed ID: 17676322
    [Abstract] [Full Text] [Related]

  • 10. Subcutaneous recombinant granulocyte-macrophage colony-stimulating factor used as a single agent and in an alternating regimen with azidothymidine in leukopenic patients with severe human immunodeficiency virus infection.
    Pluda JM, Yarchoan R, Smith PD, McAtee N, Shay LE, Oette D, Maha M, Wahl SM, Myers CE, Broder S.
    Blood; 1990 Aug 01; 76(3):463-72. PubMed ID: 2198957
    [Abstract] [Full Text] [Related]

  • 11. Recombinant granulocyte colony-stimulating factor (rG-CSF) in HIV patients with zidovudine related neutropenia.
    Clumeck N, Wit SD, Hermans P, Franchioly P, Sommereijns B.
    J Nutr Sci Vitaminol (Tokyo); 1992 Aug 01; Spec No():353-6. PubMed ID: 1284305
    [No Abstract] [Full Text] [Related]

  • 12. Phase I/II study of combined granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor administration for the mobilization of hematopoietic progenitor cells.
    Winter JN, Lazarus HM, Rademaker A, Villa M, Mangan C, Tallman M, Jahnke L, Gordon L, Newman S, Byrd K, Cooper BW, Horvath N, Crum E, Stadtmauer EA, Conklin E, Bauman A, Martin J, Goolsby C, Gerson SL, Bender J, O'Gorman M.
    J Clin Oncol; 1996 Jan 01; 14(1):277-86. PubMed ID: 8558209
    [Abstract] [Full Text] [Related]

  • 13. Safety and tolerance of intermittent intravenous and oral zidovudine therapy in human immunodeficiency virus-infected pediatric patients. Pediatric Zidovudine Phase I Study Group.
    McKinney RE, Pizzo PA, Scott GB, Parks WP, Maha MA, Lehrman SN, Riggs M, Eddy J, Lane BA, Eppes SC.
    J Pediatr; 1990 Apr 01; 116(4):640-7. PubMed ID: 2181102
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics of recombinant human granulocyte-macrophage colony-stimulating factor: the effects of zidovudine.
    Aweeka FT, Kwong M, Mak M, al-Uzri A, Affrime M, Cutler D, Kahn J, Gambertoglio JG.
    J Clin Pharmacol; 1996 Dec 01; 36(12):1107-13. PubMed ID: 9013366
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics of recombinant human granulocyte-macrophage colony-stimulating factor in children after intravenous and subcutaneous administration.
    Stute N, Furman WL, Schell M, Evans WE.
    J Pharm Sci; 1995 Jul 01; 84(7):824-8. PubMed ID: 7562431
    [Abstract] [Full Text] [Related]

  • 16. Combination of ganciclovir and granulocyte-macrophage colony-stimulating factor in the treatment of cytomegalovirus retinitis in AIDS patients. The ACTG 073 Team.
    Hardy D, Spector S, Polsky B, Crumpacker C, van der Horst C, Holland G, Freeman W, Heinemann MH, Sharuk G, Klystra J.
    Eur J Clin Microbiol Infect Dis; 1994 Jul 01; 13 Suppl 2():S34-40. PubMed ID: 7875151
    [Abstract] [Full Text] [Related]

  • 17. Priming of neutrophil and monocyte activation in human immunodeficiency virus infection. Comparison of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor and interferon-gamma.
    Meyer CN, Nielsen H.
    APMIS; 1996 Sep 01; 104(9):640-6. PubMed ID: 8972688
    [Abstract] [Full Text] [Related]

  • 18. Recombinant human GM-CSF treatment of neutropenia in glycogen storage disease-1b.
    Hurst D, Kilpatrick L, Becker J, Lipani J, Kleman K, Perrine S, Douglas SD.
    Am J Pediatr Hematol Oncol; 1993 Feb 01; 15(1):71-6. PubMed ID: 8447561
    [Abstract] [Full Text] [Related]

  • 19. A randomized, placebo-controlled trial of granulocyte-macrophage colony-stimulating factor and nucleoside analogue therapy in AIDS.
    Brites C, Gilbert MJ, Pedral-Sampaio D, Bahia F, Pedroso C, Alcantara AP, Sasaki MD, Matos J, Renjifo B, Essex M, Whitmore JB, Agosti JM, Badaro R.
    J Infect Dis; 2000 Nov 01; 182(5):1531-5. PubMed ID: 11023477
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.